Depo-Provera Contraceptive Manufacturer Pfizer Target of Consumer Lawsuit, Brain Tumors Linked to Use, According to Law Firm FeganScott
Portfolio Pulse from
A class-action lawsuit has been filed against Pfizer and Viatris, alleging that their contraceptive product, Depo-Provera, is linked to brain tumors. The lawsuit claims the companies were aware of studies from the 1980s showing a connection between the hormones in Depo-Provera and intracranial meningiomas.
January 17, 2025 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pfizer is facing a class-action lawsuit alleging that its contraceptive product, Depo-Provera, is linked to brain tumors. The lawsuit claims Pfizer was aware of studies from the 1980s showing this risk.
The lawsuit could negatively impact Pfizer's stock price due to potential legal liabilities and reputational damage. The claim that Pfizer was aware of the risks since the 1980s could exacerbate investor concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Viatris is also named in a class-action lawsuit alleging that its contraceptive product, Depo-Provera, is linked to brain tumors. The lawsuit claims Viatris was aware of studies from the 1980s showing this risk.
Similar to Pfizer, Viatris could see a negative impact on its stock price due to the lawsuit, which raises concerns about legal liabilities and potential damage to its reputation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90